Clinical research scientists

Biostatistics has been recognized and extensively employed as an indispensable tool for planning, conduct, and interpretation of clinical trials. In clinical research and development the biostatistician plays an important role that contributes toward the success of clinical trials. Well-prepared and open communication among clinicians, biostatisticians, and other related clinical research scientists will result in a successful clinical trial. 

Many of the decisions to be made by the team, and particularly by the investigators, pose ethical dilemmas. Legislation has been enacted to protect human research subjects. Recently, the most pressing ethical dilemma facing the clinical research scientist concerned biotechnology and genetic engineering research. 

The most recent pressing ethical dilemma facing the clinical research scientist surroimds the increasing amoimt of research that is being conducted in biotechni-cal and genetic engineering. Ethical issues will continue to play important parts in the medical and legal worlds. Whereas pure science is value-neutral, its application is always open to debate. Undesirable extremes are likely to exist at both ends of the spectrum. 

Given the uncertainty of clinical research, one major asset of any clinical research scientist is flexibility. If this is combined with an aptitude for self-motivation, as well as team working, then the individual should be well qualified for the task. 

Similarly, clinical trial strategy teams bring together clinical research scientists with statisticians, data managers, regulatory executives, pharmaceutical physicians and marketing managers to discuss the clinical data that is needed, and the time scales and costs, to achieve specific commercial objectives. 

Associate Clinical Research Scientist, and Clinical Assistant Professor, Abbott Laboratories and University of Minnesota, Minneapolis, Minnesota Chapter 123... 

A clinical research scientist to provide input into study designs so that the generated results support the proposed clinical program and to initiate development of clinical safety and tolerance and efficacy protocols and the investigator s brochure... 

Antigen Retrieval Immunohistochemistry Based Research Diagnostics is intended for clinical pathologists, molecular cell biologists, basic research scientists, technicians, and graduate students who undertake tissue/cell morphologic and molecular analysis and wish to use and extend the power of immunohistochemistry. It is our hope that the readers will find it informative and useful. 

Van M. Sim, M.D. (1922-1990) Trained as an internist, he was Chief of Clinical Research from 195S1961 and Chief Scientist of the Medical Research Laboratories thereafter. 

Clearly, therefore, those involved in drug safety monitoring need to liase closely with both clinical research and medical information scientists. In addition, those responsible for clinical drug safety must undertake periodic safety update reports (PSURs) at predetermined intervals, in accordance with current International Conference on Harmonisation (ICH) guidelines. Such routine analyses can identify new safety signals as soon as they become detectable. 

For more than 50 years, scientists, physicians, bioethi-cists, and the media have focused on a variety of issues in research with human subjects, or clinical research. In 1948, in response to the atrocities perpetrated by Nazi experimentation, the Nuremberg Code was developed to set forth guidelines for the acceptable conduct of scientific research. In 1964 the World Medical Association adopted the Declaration of Helsinki, which specifically guides physicians in biomedical research. These documents specify basic moral guidelines ultimately founded on concerns for autonomy, beneficence, and justice. The guidelines require the following ... 

This work was supported by National Institute of Mental Health Center Grant MH-43878 to the Center to Study Youth Depression, Anxiety and Suicide National Institute of Mental Health Mental Health Clinical Research Center Grant MH-30906 National Institute of Mental Health Research Training Grant MH-16432 Research Scientist Development Award MH-00416 to J.M.G. Research Scientist Development Award MH-00858 to L.A.P. Research Scientist Development Award MH-01039 to J.D.C. and a grant from the Lowenstein Foundation. 

The SNA research going on throughout the world at about the time of the Edgewood studies Is relevant to this study. The experiments at Edgewood were not unusual and did not Involve extraordinary doses (see Table 3-1) or special populations of volunteers, compared with experiments In the laboratories and clinics of scientists and clinical researchers throughout the world. 

Clinical Trials—Drug studies in humans can begin only after an IND is reviewed by the FDA and a local institutional review board (IRB). The board is a panel of scientists and non-scientists in hospitals and research institutions that oversees clinical research. 

Paul H. Gamache, Vice President, ESA Biosciences, Inc., Chelmsford, MA Jason S. Gobey, Associate Director, Pfizer Global Research and Development, Clinical Research Operations, New London, CT Michael C. Granger, USTAR Research Scientist, University of Utah, Center for Nanobiosensors, Salt Lake City, UT... 

---